25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Shukra Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyze Shukra Pharmaceuticals Ltd together

I guess you are interested in Shukra Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shukra Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Shukra Pharmaceuticals Ltd

I send you an email if I find something interesting about Shukra Pharmaceuticals Ltd.

1. Quick Overview

1.1. Quick analysis of Shukra Pharmaceuticals Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Shukra Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
INR13.16
Expected worth in 1 year
INR1.19
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
INR-11.91
Return On Investment
-19.2%

For what price can you sell your share?

Current Price per Share
INR61.95
Expected price per share
INR40.34 - INR78.20
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Shukra Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)
INR61.95
Intrinsic Value Per Share
INR-21.74 - INR110.37
Total Value Per Share
INR-8.58 - INR123.53

2.2. Growth of Shukra Pharmaceuticals Ltd (5 min.)




Is Shukra Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$6.8m$3m$3.8m56.1%

How much money is Shukra Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.2m$524.3k$1.6m76.2%
Net Profit Margin24.9%7.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Shukra Pharmaceuticals Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Shukra Pharmaceuticals Ltd?

Welcome investor! Shukra Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Shukra Pharmaceuticals Ltd.

First you should know what it really means to hold a share of Shukra Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shukra Pharmaceuticals Ltd is INR61.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shukra Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shukra Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR13.16. Based on the TTM, the Book Value Change Per Share is INR-2.99 per quarter. Based on the YOY, the Book Value Change Per Share is INR10.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shukra Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.050.1%0.050.1%0.030.1%0.020.0%0.020.0%
Usd Book Value Change Per Share-0.04-0.1%-0.04-0.1%0.130.2%-0.20-0.3%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.04-0.1%-0.04-0.1%0.130.2%-0.20-0.3%0.030.0%
Usd Price Per Share3.89-3.89-0.56-0.94-0.80-
Price to Earnings Ratio77.14-77.14-16.67-58.47-49.16-
Price-to-Total Gains Ratio-109.67--109.67-4.36--13.75--10.99-
Price to Book Ratio24.81-24.81-2.90-6.36-5.31-
Price-to-Total Gains Ratio-109.67--109.67-4.36--13.75--10.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.737205
Number of shares1356
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.04-0.20
Usd Total Gains Per Share-0.04-0.20
Gains per Quarter (1356 shares)-48.05-274.25
Gains per Year (1356 shares)-192.20-1,096.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-193-2021-1098-1107
22-386-3942-2196-2204
33-580-5862-3293-3301
44-773-7783-4391-4398
55-966-9704-5489-5495
66-1159-11625-6587-6592
77-1353-13546-7685-7689
88-1546-15466-8782-8786
99-1739-17387-9880-9883
1010-1932-19308-10978-10980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%2.00.03.040.0%3.00.03.050.0%3.00.03.050.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Shukra Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.994-2.9940%10.723-128%-17.008+468%2.194-236%
Book Value Per Share--13.16313.1630%16.157-19%27.674-52%39.429-67%
Current Ratio--3.9733.9730%1.249+218%2.172+83%2.271+75%
Debt To Asset Ratio--0.2590.2590%0.663-61%0.512-49%0.503-48%
Debt To Equity Ratio--0.3500.3500%1.963-82%1.184-70%1.128-69%
Dividend Per Share--0.0160.0160%0.046-66%0.013+28%0.094-83%
Eps--4.2334.2330%2.814+50%1.517+179%1.756+141%
Free Cash Flow Per Share---1.589-1.5890%-0.844-47%-2.674+68%-4.560+187%
Free Cash Flow To Equity Per Share---1.589-1.5890%-0.844-47%-0.126-92%0.096-1746%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--110.370--------
Intrinsic Value_10Y_min---21.743--------
Intrinsic Value_1Y_max--2.313--------
Intrinsic Value_1Y_min---2.575--------
Intrinsic Value_3Y_max--13.616--------
Intrinsic Value_3Y_min---7.440--------
Intrinsic Value_5Y_max--32.955--------
Intrinsic Value_5Y_min---11.942--------
Market Cap--14298953113.20014298953113.2000%734771277.500+1846%3138136817.591+356%2617099160.086+446%
Net Profit Margin--0.2490.2490%0.075+232%0.076+227%0.077+223%
Operating Margin----0%-0%0.001-100%0.021-100%
Operating Ratio--1.3641.3640%1.710-20%1.399-2%1.341+2%
Pb Ratio4.706-427%24.80824.8080%2.905+754%6.362+290%5.315+367%
Pe Ratio14.634-427%77.13777.1370%16.675+363%58.472+32%49.157+57%
Price Per Share61.950-427%326.550326.5500%46.930+596%79.063+313%67.154+386%
Price To Free Cash Flow Ratio-38.994+81%-205.542-205.5420%-55.601-73%-55.499-73%-46.340-77%
Price To Total Gains Ratio-20.805+81%-109.666-109.6660%4.358-2617%-13.755-87%-10.988-90%
Quick Ratio--2.4372.4370%0.710+243%1.352+80%1.549+57%
Return On Assets--0.2380.2380%0.059+305%0.065+267%0.057+319%
Return On Equity--0.3220.3220%0.174+85%0.111+189%0.098+229%
Total Gains Per Share---2.978-2.9780%10.770-128%-16.996+471%2.288-230%
Usd Book Value--6859112.4006859112.4000%3010307.300+128%3101062.298+121%2889166.617+137%
Usd Book Value Change Per Share---0.036-0.0360%0.128-128%-0.202+468%0.026-236%
Usd Book Value Per Share--0.1570.1570%0.192-19%0.329-52%0.469-67%
Usd Dividend Per Share--0.0000.0000%0.001-66%0.000+28%0.001-83%
Usd Eps--0.0500.0500%0.033+50%0.018+179%0.021+141%
Usd Free Cash Flow---827847.300-827847.3000%-157258.500-81%-120803.773-85%-144109.278-83%
Usd Free Cash Flow Per Share---0.019-0.0190%-0.010-47%-0.032+68%-0.054+187%
Usd Free Cash Flow To Equity Per Share---0.019-0.0190%-0.010-47%-0.001-92%0.001-1746%
Usd Market Cap--170157542.047170157542.0470%8743778.202+1846%37343828.129+356%31143480.005+446%
Usd Price Per Share0.737-427%3.8863.8860%0.558+596%0.941+313%0.799+386%
Usd Profit--2205926.8002205926.8000%524373.500+321%569250.875+288%483538.130+356%
Usd Revenue--8874175.1008874175.1000%7001210.300+27%4211046.326+111%3621454.648+145%
Usd Total Gains Per Share---0.035-0.0350%0.128-128%-0.202+471%0.027-230%
 EOD+4 -2MRQTTM+0 -0YOY+17 -175Y+25 -1010Y+18 -17

3.3 Fundamental Score

Let's check the fundamental score of Shukra Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.634
Price to Book Ratio (EOD)Between0-14.706
Net Profit Margin (MRQ)Greater than00.249
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.437
Current Ratio (MRQ)Greater than13.973
Debt to Asset Ratio (MRQ)Less than10.259
Debt to Equity Ratio (MRQ)Less than10.350
Return on Equity (MRQ)Greater than0.150.322
Return on Assets (MRQ)Greater than0.050.238
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of Shukra Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.110
Ma 20Greater thanMa 5065.065
Ma 50Greater thanMa 10067.320
Ma 100Greater thanMa 20070.220
OpenGreater thanClose63.400
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Shukra Pharmaceuticals Ltd

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Shukra Pharmaceuticals Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Shukra Pharmaceuticals Ltd to the  industry mean.
  • A Net Profit Margin of 24.9% means that ₹0.25 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 24.9%. The company is making a huge profit. +2
  • The TTM is 24.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ24.9%TTM24.9%0.0%
TTM24.9%YOY7.5%+17.4%
TTM24.9%5Y7.6%+17.3%
5Y7.6%10Y7.7%-0.1%
4.3.1.2. Return on Assets

Shows how efficient Shukra Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shukra Pharmaceuticals Ltd to the  industry mean.
  • 23.8% Return on Assets means that Shukra Pharmaceuticals Ltd generated ₹0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 23.8%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 23.8%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ23.8%TTM23.8%0.0%
TTM23.8%YOY5.9%+17.9%
TTM23.8%5Y6.5%+17.3%
5Y6.5%10Y5.7%+0.8%
4.3.1.3. Return on Equity

Shows how efficient Shukra Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shukra Pharmaceuticals Ltd to the  industry mean.
  • 32.2% Return on Equity means Shukra Pharmaceuticals Ltd generated ₹0.32 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 32.2%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 32.2%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ32.2%TTM32.2%0.0%
TTM32.2%YOY17.4%+14.7%
TTM32.2%5Y11.1%+21.0%
5Y11.1%10Y9.8%+1.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Shukra Pharmaceuticals Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Shukra Pharmaceuticals Ltd is operating .

  • Measures how much profit Shukra Pharmaceuticals Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shukra Pharmaceuticals Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.1%-0.1%
5Y0.1%10Y2.1%-2.0%
4.3.2.2. Operating Ratio

Measures how efficient Shukra Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.36 means that the operating costs are ₹1.36 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 1.364. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.364. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.364TTM1.3640.000
TTM1.364YOY1.710-0.346
TTM1.3645Y1.399-0.035
5Y1.39910Y1.341+0.058
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Shukra Pharmaceuticals Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Shukra Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 3.97 means the company has ₹3.97 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 3.973. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.973. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.973TTM3.9730.000
TTM3.973YOY1.249+2.725
TTM3.9735Y2.172+1.801
5Y2.17210Y2.271-0.100
4.4.3.2. Quick Ratio

Measures if Shukra Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shukra Pharmaceuticals Ltd to the  industry mean.
  • A Quick Ratio of 2.44 means the company can pay off ₹2.44 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 2.437. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.437. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.437TTM2.4370.000
TTM2.437YOY0.710+1.727
TTM2.4375Y1.352+1.085
5Y1.35210Y1.549-0.197
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Shukra Pharmaceuticals Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Shukra Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shukra Pharmaceuticals Ltd to industry mean.
  • A Debt to Asset Ratio of 0.26 means that Shukra Pharmaceuticals Ltd assets are financed with 25.9% credit (debt) and the remaining percentage (100% - 25.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 0.259. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.259. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.259TTM0.2590.000
TTM0.259YOY0.663-0.403
TTM0.2595Y0.512-0.252
5Y0.51210Y0.503+0.009
4.5.4.2. Debt to Equity Ratio

Measures if Shukra Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shukra Pharmaceuticals Ltd to the  industry mean.
  • A Debt to Equity ratio of 35.0% means that company has ₹0.35 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shukra Pharmaceuticals Ltd:

  • The MRQ is 0.350. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.350. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.350TTM0.3500.000
TTM0.350YOY1.963-1.613
TTM0.3505Y1.184-0.834
5Y1.18410Y1.128+0.056
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Shukra Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Shukra Pharmaceuticals Ltd to the  industry mean.
  • A PE ratio of 77.14 means the investor is paying ₹77.14 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shukra Pharmaceuticals Ltd:

  • The EOD is 14.634. Based on the earnings, the company is underpriced. +1
  • The MRQ is 77.137. Based on the earnings, the company is expensive. -2
  • The TTM is 77.137. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD14.634MRQ77.137-62.503
MRQ77.137TTM77.1370.000
TTM77.137YOY16.675+60.462
TTM77.1375Y58.472+18.664
5Y58.47210Y49.157+9.316
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shukra Pharmaceuticals Ltd:

  • The EOD is -38.994. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -205.542. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -205.542. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.994MRQ-205.542+166.549
MRQ-205.542TTM-205.5420.000
TTM-205.542YOY-55.601-149.941
TTM-205.5425Y-55.499-150.043
5Y-55.49910Y-46.340-9.159
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Shukra Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 24.81 means the investor is paying ₹24.81 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Shukra Pharmaceuticals Ltd:

  • The EOD is 4.706. Based on the equity, the company is fair priced.
  • The MRQ is 24.808. Based on the equity, the company is expensive. -2
  • The TTM is 24.808. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4.706MRQ24.808-20.101
MRQ24.808TTM24.8080.000
TTM24.808YOY2.905+21.903
TTM24.8085Y6.362+18.445
5Y6.36210Y5.315+1.047
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets778,371
Total Liabilities201,975
Total Stockholder Equity576,396
 As reported
Total Liabilities 201,975
Total Stockholder Equity+ 576,396
Total Assets = 778,371

Assets

Total Assets778,371
Total Current Assets562,326
Long-term Assets216,045
Total Current Assets
Short-term Investments 99,804
Net Receivables 245,129
Inventory 23,144
Other Current Assets 171,048
Total Current Assets  (as reported)562,326
Total Current Assets  (calculated)539,125
+/- 23,201
Long-term Assets
Property Plant Equipment 216,045
Long-term Assets  (as reported)216,045
Long-term Assets  (calculated)216,045
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities141,532
Long-term Liabilities60,443
Total Stockholder Equity576,396
Total Current Liabilities
Short Long Term Debt 4,972
Accounts payable 72,214
Other Current Liabilities 56,474
Total Current Liabilities  (as reported)141,532
Total Current Liabilities  (calculated)133,660
+/- 7,872
Long-term Liabilities
Long term Debt 26,567
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)60,443
Long-term Liabilities  (calculated)26,568
+/- 33,875
Total Stockholder Equity
Total Stockholder Equity (as reported)576,396
Total Stockholder Equity (calculated)0
+/- 576,396
Other
Capital Stock109,470
Common Stock Shares Outstanding 43,788
Net Debt 31,539
Net Invested Capital 607,935
Net Working Capital 420,794
Property Plant and Equipment Gross 216,045



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
283,903
335,452
356,081
351,127
749,664
778,371
778,371749,664351,127356,081335,452283,90300
   > Total Current Assets 
70,796
82,749
110,730
144,344
160,601
158,715
530,717
562,326
562,326530,717158,715160,601144,344110,73082,74970,796
       Cash And Cash Equivalents 
0
0
2,485
1,264
5,044
2,896
39,731
0
039,7312,8965,0441,2642,48500
       Short-term Investments 
0
0
0
0
34,289
0
0
99,804
99,8040034,2890000
       Net Receivables 
61,033
77,757
101,298
79,512
97,478
74,008
301,867
245,129
245,129301,86774,00897,47879,512101,29877,75761,033
       Inventory 
3,162
1,448
2,707
13,187
16,815
39,540
31,567
23,144
23,14431,56739,54016,81513,1872,7071,4483,162
       Other Current Assets 
1,365
2,905
4,240
2,993
1
1
132,178
171,048
171,048132,178112,9934,2402,9051,365
   > Long-term Assets 
0
0
173,173
190,932
195,480
192,412
218,947
216,045
216,045218,947192,412195,480190,932173,17300
       Property Plant Equipment 
118,135
157,791
172,656
190,409
193,532
192,400
218,900
216,045
216,045218,900192,400193,532190,409172,656157,791118,135
> Total Liabilities 
0
0
130,148
181,341
200,088
187,627
496,697
201,975
201,975496,697187,627200,088181,341130,14800
   > Total Current Liabilities 
17,203
26,650
39,968
69,682
70,349
123,765
425,062
141,532
141,532425,062123,76570,34969,68239,96826,65017,203
       Short Long Term Debt 
0
0
0
0
0
2,497
13,132
4,972
4,97213,1322,49700000
       Accounts payable 
1,069
2,216
1,287
64,436
53,290
85,900
342,506
72,214
72,214342,50685,90053,29064,4361,2872,2161,069
       Other Current Liabilities 
3,631
2,949
7,267
5,246
0
1
-1
56,474
56,474-1105,2467,2672,9493,631
   > Long-term Liabilities 
0
0
90,180
111,482
129,739
63,862
71,635
60,443
60,44371,63563,862129,739111,48290,18000
       Long-term Liabilities Other 
0
0
0
0
0
-2
1,083
1
11,083-200000
> Total Stockholder Equity
0
0
153,755
154,111
155,993
163,500
252,967
576,396
576,396252,967163,500155,993154,111153,75500
   Common Stock
15,657
15,657
15,657
15,657
0
0
0
0
000015,65715,65715,65715,657
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
40,276
40,276
40,276
138,455
0
0
0
0
0000138,45540,27640,27640,276



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue745,729
Cost of Revenue-444,864
Gross Profit300,865300,865
 
Operating Income (+$)
Gross Profit300,865
Operating Expense-572,198
Operating Income173,531-271,333
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense572,1980
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,850
Other Finance Cost-0
Net Interest Income-2,850
 
Pretax Income (+$)
Operating Income173,531
Net Interest Income-2,850
Other Non-Operating Income Expenses0
Income Before Tax (EBT)198,833173,531
EBIT - interestExpense = -2,850
185,372
188,222
Interest Expense2,850
Earnings Before Interest and Taxes (EBIT)0201,683
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax198,833
Tax Provision-13,461
Net Income From Continuing Ops185,372185,372
Net Income185,372
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,850
 

Technical Analysis of Shukra Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shukra Pharmaceuticals Ltd. The general trend of Shukra Pharmaceuticals Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shukra Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shukra Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 74.99 < 78.09 < 78.20.

The bearish price targets are: 58.08 > 57.52 > 40.34.

Tweet this
Shukra Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shukra Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shukra Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shukra Pharmaceuticals Ltd. The current macd is -2.1171716.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shukra Pharmaceuticals Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shukra Pharmaceuticals Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shukra Pharmaceuticals Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shukra Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShukra Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shukra Pharmaceuticals Ltd. The current adx is 20.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shukra Pharmaceuticals Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Shukra Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shukra Pharmaceuticals Ltd. The current sar is 67.30.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shukra Pharmaceuticals Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shukra Pharmaceuticals Ltd. The current rsi is 43.11. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Shukra Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartShukra Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shukra Pharmaceuticals Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shukra Pharmaceuticals Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Shukra Pharmaceuticals Ltd Daily Stochastic Oscillator ChartShukra Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shukra Pharmaceuticals Ltd. The current cci is -60.82321587.

Shukra Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartShukra Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shukra Pharmaceuticals Ltd. The current cmo is -12.97370669.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shukra Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartShukra Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shukra Pharmaceuticals Ltd. The current willr is -66.64156627.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shukra Pharmaceuticals Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shukra Pharmaceuticals Ltd Daily Williams %R ChartShukra Pharmaceuticals Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shukra Pharmaceuticals Ltd.

Shukra Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shukra Pharmaceuticals Ltd. The current atr is 3.65711114.

Shukra Pharmaceuticals Ltd Daily Average True Range (ATR) ChartShukra Pharmaceuticals Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shukra Pharmaceuticals Ltd. The current obv is 4,325,403.

Shukra Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartShukra Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shukra Pharmaceuticals Ltd. The current mfi is 22.38.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Shukra Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartShukra Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shukra Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Shukra Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shukra Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.110
Ma 20Greater thanMa 5065.065
Ma 50Greater thanMa 10067.320
Ma 100Greater thanMa 20070.220
OpenGreater thanClose63.400
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Shukra Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shukra Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shukra Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shukra Pharmaceuticals Ltd

I send you an email if I find something interesting about Shukra Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shukra Pharmaceuticals Ltd.

Receive notifications about Shukra Pharmaceuticals Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.